Gatorade, inventor of the sports drink, is getting a rebrand targeting non-athletes - AP News
Quick Insights
The Bottom Line
Gatorade, the inventor of sports drinks, is rebranding to target non-athletes.
AI Summary
Gatorade, known as the inventor of the sports drink, is undergoing a rebrand to appeal to a broader audience beyond athletes. This strategic shift aims to expand the company's market reach by targeting non-athletes. The move signifies a departure from Gatorade's traditional focus on performance and athletic hydration. This rebrand could introduce new product lines or marketing strategies designed for everyday consumption.
Following this story?
Get notified when new coverage appears
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
CorporateWomen take the lead in whiskey as more female drinkers and distillers change the industry - AP News
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNNkJpbnUwNTFHelBXTmlpdVJVT3pYZGVnVlB4TVB0MmkySjhmZjZLMUljRVFVbTB4UWFJVXhFSFZ4SHJ0bHRhMldndkowWWJYaERlUG41RFpkQl96YV9oUk0yU0JyS1poVWRvWHNXOFJ4dGFURWYtRFIwcGllaUd2MFpR?oc=5" target="_blank">Women take the lead in whiskey as more female drinkers and distillers change the industry</a> <font color="#6f6f6f">AP News</font>
PoliticsU.S. lawmakers scale back bill targeting Chinese chipmaking - Reuters
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZDVjY3o4LThVWVQydjdDakVRLWNoMHgxcVM3MzhfYUhTdXJMS3hkSDFBSVVZWEhUbUlJRGgyVGhtaElBUVRUQThrbjhHc2M3Z1c1SFVxd3BmaElCMTRsaGk5MWtPc04tUWNNdDU0eUxQcXI1ZXE2QjZTc2ROY3hoN1VEQk1OdE9xTk4tb0lBT0doeVRKUG9yOWxiMWo1dURzTnhSRTdMRFU?oc=5" target="_blank">U.S. lawmakers scale back bill targeting Chinese chipmaking</a> <font color="#6f6f6f">Reuters</font>
PoliticsKash Patel sues the Atlantic over article alleging excessive drinking
<p>Magazine has stood behind the story, which was written by veteran national security reporter Sarah Fitzpatrick</p><p>Kash Patel has followed through on a threat to sue the Atlantic and the author of <a href="https://www.theatlantic.com/politics/2026/04/kash-patel-fbi-director-drinking-absences/686839/">a story the magazine published</a> that included allegations of “excessive drinking” as well as “conspicuous inebriation and unexplained absences” while in charge of the law enforcement agency.</p><p>The US attorney general filed a defamation lawsuit in US district court for the District of Columbia that seeks $250m in damages.</p> <a href="https://www.theguardian.com/us-news/2026/apr/20/kash-patel-lawsuit-the-atlantic">Continue reading...</a>
Government TransparencyWhat to Know About Allegations of Excessive Drinking by FBI Director Kash Patel
Kash Patel denies allegations of excessive drinking and absences as officials cited in report raise concerns about FBI leadership
PoliticsPatel says he’ll sue Atlantic for defamation over report on heavy drinking
FBI Director Kash Patel said Sunday that he will sue The Atlantic for defamation after the magazine published a Friday story detailing his alleged drinking habits and absences from the bureau. “Absolutely. It’s coming tomorrow,” he told host Maria Bartiromo on Fox News’s “Sunday Morning Futures” about the forthcoming lawsuit. The FBI director later said…
GlobalMiddle East conflict causes a fluoride shortage for US drinking water
Some U.S. water systems are cutting back on fluoride because of a key chemical is in short supply. Israel is one of its main producers.
Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case
<p>Under settlement, Sackler family will pay state, local and Native American tribal governments, individual victims and others</p><ul><li><p><a href="https://www.theguardian.com/news/2026/feb/17/sign-up-for-the-breaking-news-us-email-to-get-newsletter-alerts-direct-to-your-inbox?utm_medium=ACQUISITIONS_STANDFIRST&utm_campaign=BN22326&utm_content=signup&utm_term=standfirst&utm_source=GUARDIAN_WEB">Sign up for the Breaking News US email to get newsletter alerts in your inbox</a></p></li></ul><p>A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225m to the US justice department on Tuesday, clearing the way for the company to finalize <a href="https://www.theguardian.com/us-news/2025/nov/18/purdue-pharma-opioid-settlement-oxycontin">a settlement</a> of thousands of lawsuits it faces over its role in the opioid crisis.</p><p>The penalty was agreed to in a 2020 pact to resolve federal civil and criminal investigations it was facing. If the judge si...
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
One in three Americans forced to make financial sacrifices for health coverage
Airline mega-merger story is all about Trump
Pope blasts ‘tyrants’ ravaging the Earth during his visit to Cameroon - AP News
Justice Jackson chides Supreme Court conservatives over 'oblivious' pro-Trump emergency orders - AP News
